Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors

Related articles

1. Characterization and predictive value of lymphocyte subsets in peripheral blood of patients with colorectal cancer

   This article has 5 authors:

   1. Guanghai Wu
   2. Kunming Zheng
   3. Wang Han
   4. Shichao Xu
   5. Jing Xu

2. Autologous Cytokine-induced Killer Cell Combination Therapy Enhances Response to Immune Checkpoint Inhibitors in Patients with Refractory Clear Cell Renal Cell Carcinoma

   This article has 22 authors:

   1. Shuzhan Li
   2. Jing Qin
   3. Qian Sun
   4. Hua Zhao
   5. Yanjuan Xiong
   6. Yang Wang
   7. Ying Han
   8. Jiali Zhang
   9. Weihong Zhang
   10. Meng Shen
   11. Fan Yang
   12. Baozhu Ren
   13. Li Zhou
   14. Runmei Li
   15. Zhenzhen Hui
   16. Xiao Tian
   17. Shui Cao
   18. Weijiao Du
   19. Wenwen Yu
   20. Liang Liu
   21. Xinwei Zhang
   22. Xiubao Ren

3. Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes

   This article has 23 authors:

   1. Kazuhiro Kou
   2. Mayu Fukuda
   3. Koji Yamanoi
   4. Nobutaka Hayashi
   5. Hisateru Yasui
   6. Takuma Hayashi
   7. Yoshihiro Yakushijin
   8. Takehiko Tsumura
   9. Atsushi Shirakawa
   10. Chiho Nakashima
   11. Yoshinori Imamura
   12. Chikako Yamauchi
   13. Toshio Shimizu
   14. Takahito Ashihara
   15. Nobuhiro Shibata
   16. Takeshi Kotake
   17. Aya Toyofuku
   18. Taito Miyamoto
   19. Rin Mizuno
   20. Mana Taki
   21. Ryusuke Murakami
   22. Manabu Muto
   23. Masaki Mandai